Real-world treatment and survival outcome of malignant giant cell tumor of bone in the pre-denosumab versus post-denosumab era.
第一作者:
Xianglin,Hu
第一单位:
Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
作者:
医学主题词
骨密度保护剂(Bone Density Conservation Agents);骨肿瘤(Bone Neoplasms);骨巨细胞瘤(Giant Cell Tumor of Bone);人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);治疗结果(Treatment Outcome)
DOI
10.1016/j.ijsu.2022.106667
PMID
35562002
发布时间
2022-06-19
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



